2nd Affiliated Hospital, School of Medicine, Zhejiang University
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neoadjuvant Trastuzumab-rezetecan Plus Pertuzumab or Nab-Paclitaxel, Carboplatin, Trastuzumab, and Pyrotinib After Suboptimal Response to Neoadjuvant Dual HER2-Targeted Therapy Combined With Chemotherapy in HER2-Positive Early Breast Cancer | HER2-positive Early Breast Cancer | Recruiting | Phase 2 | 2026-01-21 | NCT07340398 |